Miguel Fernandez
Chief Tech/Sci/R&D Officer presso STADA ARZNEIMITTEL
Posizioni attive di Miguel Fernandez
Società | Posizione | Inizio | Fine |
---|---|---|---|
STADA ARZNEIMITTEL | Chief Tech/Sci/R&D Officer | 01/01/2015 | - |
Storia della carriera di Miguel Fernandez
Precedenti posizioni note di Miguel Fernandez
Società | Posizione | Inizio | Fine |
---|---|---|---|
Merck Sharp & Dohme (Europe), Inc. | Corporate Officer/Principal | - | - |
MERCK & CO., INC. | Corporate Officer/Principal | - | - |
NOVARTIS AG | Corporate Officer/Principal | - | - |
Formazione di Miguel Fernandez
Madrid University | Graduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 3 |
Svizzera | 2 |
Germania | 2 |
Posizioni
Corporate Officer/Principal | 3 |
Chief Tech/Sci/R&D Officer | 1 |
Graduate Degree | 1 |
Settori
Health Technology | 4 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
MERCK & CO., INC. | Health Technology |
NOVARTIS AG | Health Technology |
Aziende private | 2 |
---|---|
STADA Arzneimittel AG
STADA Arzneimittel AG Pharmaceuticals: OtherHealth Technology STADA Arzneimittel AG engages in the provision of healthcare and pharmaceutical products. It operates through the following segments: Generics, Consumer Healthcare, and Specialty. The Generics segment produces and distributes generic drugs. The Consumer Healthcare segment includes products such as OTC drugs, nutritional supplements and certain consumer healthcare products such as disinfectants and sunscreen. The Specialty segment includes branded generics, specialty generics, and biosimilars. Its brands include Zoflora, Grippostad, Nizoral, and Shampoo & Ladival. The company was founded on March 14, 1895 and is headquartered in Bad Vilbel, Germany. | Health Technology |
Merck Sharp & Dohme (Europe), Inc. |
- Borsa valori
- Insiders
- Miguel Fernandez
- Esperienza